Evidence map›Paper›PMID 35919814›Full record

ArticleInternational journal of medical sciences2022

A one-year follow-up study on dynamic changes of leukocyte subsets and virus-specific antibodies of patients with COVID-19 in Sichuan, China.

Renjie Xu, Bennan Zhao, Lijuan Lan, Yaling Liu, Yalun Li, Liangshuang Jiang, Shuiping Dai

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of medical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Renjie XuInstitute of Respiratory Health, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Bennan ZhaoDepartment of Comprehensive Internal Medicine, the Public and Health Clinical Center of Chengdu, Chengdu, Sichuan, China.
Lijuan LanDepartment of Comprehensive Internal Medicine, the Public and Health Clinical Center of Chengdu, Chengdu, Sichuan, China.
Yaling LiuDepartment of Comprehensive Internal Medicine, the Public and Health Clinical Center of Chengdu, Chengdu, Sichuan, China.
Yalun LiDepartment of Respiratory and Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Liangshuang JiangDepartment of Comprehensive Internal Medicine, the Public and Health Clinical Center of Chengdu, Chengdu, Sichuan, China.
Shuiping DaiCenter of Gerontology and Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Sichuan University · CNWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Antibodies, ViralCOVID-19 VaccinesFollow-Up StudiesHumansImmunoglobulin GLeukocytesSARS-CoV-2Antibodies, ViralCOVID-19 VaccinesImmunoglobulin GFollow-upLeukocyte subsetsSARS-CoV-2VaccineVirus-specific antibody

Identifiers

PMID35919814
PMCPMC9339420
OpenAlexW4285214382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.